EMA confirms risk positive on Astrazeneca vaccine

European Medecine Agency declared that a “possibility of very rare cases of blood clots combined with low levels of blood platelets occurring within 2 weeks of vaccination. So far, most of the cases reported have occurred in women under 60 years of age within 2 weeks of vaccination. Based on the currently available evidence, specific risk factors have not been confirmed.”

It is said also “People who have received the vaccine should seek medical assistance immediately if they develop symptoms of this combination of blood clots and low blood…